🧬 Genetic Disorder

Darier's Disease

Also known as: Darier-White Disease, Keratosis Follicularis

Darier's disease (DD) is a rare autosomal dominant skin disorder characterized by persistent, greasy, and scaling papules and plaques on the seborrheic areas of the body, such as the chest, back, scalp, and flexures. It is caused by mutations in the ATP2A2 gene, which encodes a calcium pump in the endoplasmic reticulum.

ICD-10: Q82.8 Orphanet: 219 OMIM: 124200
👥 1 in 30,000 to 1 in 100,000 Prevalence
🔬 15 Active Trials

Imagine your skin has trouble sticking together properly. Darier's Disease is like having tiny, rough bumps all over your body, especially where you sweat a lot. It can be itchy and sometimes smelly, but doctors can help you manage it with creams and medicines.

Signs & Symptoms

  • Persistent, greasy, scaling papules and plaques
  • Skin lesions in seborrheic areas (chest, back, scalp, flexures)
  • Pruritus (itching)
  • Foul odor
  • Nail abnormalities (V-shaped notches, longitudinal ridging)
  • Palmo-plantar pits
  • Oral lesions (cobblestone-like papules)
  • Increased susceptibility to skin infections
  • Neuropsychiatric disorders (depression, anxiety, epilepsy)

Treatment Options

MEDICATION FDA Approved

Topical corticosteroids

MODERATELY EFFECTIVE
MEDICATION FDA Approved

Topical retinoids (e.g., tretinoin, adapalene)

MODERATELY EFFECTIVE
MEDICATION FDA Approved

Oral retinoids (e.g., acitretin, isotretinoin)

HIGHLY EFFECTIVE
MEDICATION FDA Approved

Topical calcineurin inhibitors (e.g., tacrolimus, pimecrolimus)

MODERATELY EFFECTIVE
SURGERY

Surgical excision or laser ablation of localized lesions

MODERATELY EFFECTIVE
THERAPY

Photodynamic therapy (PDT)

MODERATELY EFFECTIVE
MEDICATION FDA Approved

Bacterial infection management with antibiotics

SUPPORTIVE
SUPPORTIVE

Supportive care (emollients, avoidance of triggers)

SUPPORTIVE

Diagnosis

  • Clinical examination
  • Skin biopsy with histopathology
  • Genetic testing for ATP2A2 mutations

History

Darier's disease was first described by French dermatologist Ferdinand-Jean Darier in 1889. He characterized the distinct skin lesions and histological features of the condition, establishing it as a unique dermatological entity.

Recent Breakthroughs

2022

CRISPR-Cas9 Gene Editing for ATP2A2 Mutations

Preclinical studies have shown promising results using CRISPR-Cas9 technology to correct ATP2A2 mutations in vitro, potentially paving the way for future gene therapy approaches for Darier's disease.

2023

Targeted Therapies for Calcium Signaling Dysfunction

Research is underway to develop targeted therapies that modulate calcium signaling pathways in keratinocytes, aiming to restore normal cell adhesion and differentiation in Darier's disease.